Publication
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).
| dc.contributor.author | Schleiermacher, G. | |
| dc.contributor.author | Michon, J. | |
| dc.contributor.author | Ribeiro, A. | |
| dc.contributor.author | Pierron, G. | |
| dc.contributor.author | Mosseri, V. | |
| dc.contributor.author | Rubie, H. | |
| dc.contributor.author | Munzer, C. | |
| dc.contributor.author | Bénard, J. | |
| dc.contributor.author | Auger, N. | |
| dc.contributor.author | Combaret, V. | |
| dc.contributor.author | Janoueix-Lerosey, I. | |
| dc.contributor.author | Pearson, A. | |
| dc.contributor.author | Tweddle, D.A. | |
| dc.contributor.author | Bown, N. | |
| dc.contributor.author | Gerrard, M. | |
| dc.contributor.author | Wheeler, K. | |
| dc.contributor.author | Noguera, R. | |
| dc.contributor.author | Villamon, E. | |
| dc.contributor.author | Cañete, A. | |
| dc.contributor.author | Castel, V. | |
| dc.contributor.author | Marques, B. | |
| dc.contributor.author | de Lacerda, A. | |
| dc.contributor.author | Tonini, G.P. | |
| dc.contributor.author | Mazzocco, K. | |
| dc.contributor.author | Defferrari, R. | |
| dc.contributor.author | de Bernardi, B. | |
| dc.contributor.author | di Cataldo, A. | |
| dc.contributor.author | van Roy, N. | |
| dc.contributor.author | Brichard, B. | |
| dc.contributor.author | Ladenstein, R. | |
| dc.contributor.author | Ambros, I. | |
| dc.contributor.author | Ambros, P. | |
| dc.contributor.author | Beiske, K. | |
| dc.contributor.author | Delattre, O. | |
| dc.contributor.author | Couturier, J. | |
| dc.date.accessioned | 2012-03-15T12:49:07Z | |
| dc.date.available | 2012-03-15T12:49:07Z | |
| dc.date.issued | 2011-12 | |
| dc.description.abstract | BACKGROUND: In neuroblastoma (NB), the presence of segmental chromosome alterations (SCAs) is associated with a higher risk of relapse. METHODS: In order to analyse the role of SCAs in infants with localised unresectable/disseminated NB without MYCN amplification, we have performed an array CGH analysis of tumours from infants enrolled in the prospective European INES trials. RESULTS: Tumour samples from 218 out of 300 enroled patients could be analysed. Segmental chromosome alterations were observed in 11%, 20% and 59% of infants enroled in trials INES99.1 (localised unresectable NB), INES99.2 (stage 4s) and INES99.3 (stage 4) (P<0.0001). Progression-free survival was poorer in patients whose tumours harboured SCA, in the whole population and in trials INES99.1 and INES99.2, in the absence of clinical symptoms (log-rank test, P=0.0001, P=0.04 and P=0.0003, respectively). In multivariate analysis, a SCA genomic profile was the strongest predictor of poorer progression-free survival. CONCLUSION: In infants with stage 4s MYCN-non-amplified NB, a SCA genomic profile identifies patients who will require upfront treatment even in the absence of other clinical indication for therapy, whereas in infants with localised unresectable NB, a genomic profile characterised by the absence of SCA identifies patients in whom treatment reduction might be possible. These findings will be implemented in a future international trial. | por |
| dc.identifier.citation | Br J Cancer. 2011 Dec 6;105(12):1940-8. Epub 2011 Nov 10 | por |
| dc.identifier.issn | 0007-0920 | |
| dc.identifier.other | doi: 10.1038/bjc.2011.472. | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/794 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Nature Publishing Group | por |
| dc.relation.publisherversion | http://www.nature.com/bjc/journal/v105/n12/full/bjc2011472a.html | por |
| dc.subject | Doenças Genéticas | por |
| dc.subject | Neuroblastoma | por |
| dc.subject | Segmental Chromosome Alterations | por |
| dc.subject | High Risk | por |
| dc.title | Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1948 | por |
| oaire.citation.startPage | 1940 | por |
| oaire.citation.title | British Journal of Cancer | por |
| rcaap.rights | restrictedAccess | por |
| rcaap.type | article | por |
